KRYS
Krystal Biotech, Inc. Common Stock
stockNASDAQ
At CloseOct 2, 2026 3:59:59 PM EDT
322.34USD-0.913%(-2.97)425,676
Loading…
Loading…
9.55B
Healthcare
Biotechnology
CEO
Krish S. Krishnan
HQ
Pittsburgh, PA, USA
Previous Close
$325.31
Beta
0.75
52-Week High
$382.54 2026-06-30
52-Week Low
$179.16 2025-10-03
SMA 50
$342.43
SMA 200
$301.37
Avg. Vol 10D
256,766
Avg. Vol 30D
273,653
Avg. Vol 90D
369,628
Relative Vol
1.56
29.60M
23.51M
79.44%
3,163,642
13.45%
13.23
63%/37%
59.10%
46.54%
0.2800%
200,000
7,408
1,796
7,408
Nov 2, 2026 (28d)
Sep 24, 2026
Krystal Biotech stock initiated at buy by Goldman Sachs · 
Investing.com
Sep 3, 2026
Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference · 
GlobeNewswire Inc.
Sep 2, 2026
Krystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue? · 
Zacks Investment Research
KRYS Profile
krystal biotech, inc. is using gene therapy to develop effective and novel treatments for skin diseases. our goal is to make a meaningful difference in the lives of underserved patient populations with debilitating skin diseases. we work to accomplish that through scientific innovation, operational excellence and believe that "nature operates in the shortest way possible". (aristotle)
KRYS Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 337.08 | 2026-09-28 | -4.29% | -0.385 |
| 1M | 358.24 | 2026-09-04 | -9.94% | 0.757 |
| 3M | 374.68 | 2026-07-06 | -13.90% | 0.214 |
| 6M | 261.80 | 2026-04-06 | +23.23% | 0.399 |
| 1Y | 183.36 | 2025-10-03 | +75.95% | 0.751 |
| 2Y | 177.11 | 2024-10-04 | +82.16% | — |
| 5Y | 54.03 | 2021-10-04 | +497.10% | 1.238 |
KRYS Stock Summary
Krystal Biotech, Inc. Common Stock (NASDAQ:KRYS) stock price today is $322.62, and today's volume is 425,676. KRYS is down 0.828% today. The 30 day average volume is 273,653. KRYS market cap is $9.55B with 29.60M shares outstanding.